University of California San Francisco
Queen Elizabeth II has awarded Regis Kelly, PhD, the title of Officer of the Most Excellent Order of the British Empire for his services to science, innovation and global health.
In a finding that directly contradicts the standard biological model of animal cell communication, UCSF scientists have discovered that typical cells in animals have the ability to transmit and receive biological signals by making physical contact with each other, even at long distance.
A collaborative model of maternity care between UCSF’s certified nurse-midwives and obstetricians that began at San Francisco General Hospital almost 40 years ago allows each to learn from one another and practice to their unique strengths.
Troy Super Sr. became the 3,000th person to receive a liver transplant at UCSF Medical Center on Dec. 13 and was able to be home in time for Christmas.
Chancellor Susan Desmond-Hellman kicked off a special day-long symposium recognizing the winners of the 2014 Breakthrough Prizes in Life Sciences on Dec. 13. It was the centerpiece of a two-day celebration hosted by UCSF.
Inside UCSF takes a quick look at some of the biggest stories of 2013 that highlight the University and the campus community.
UCSF has launched a new specialty in Clinical Informatics, addressing the growing need to harness the power of massive quantities of patient data in the era of precision medicine and health care reform.
From marriage proposals to organ transplants, 2013 was a banner year for powerful UCSF visuals both on and off campus. Help us select the best one.
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
UC San Francisco celebrated 10 years at Mission Bay, held a world-class summit on precision medicine, bid its current chancellor farewell. 2013 was a year full of milestones across UCSF. View the
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
A new study provides further proof that regular use of the the HIV antiretroviral drug Truvada can reduce one’s risk for contracting HIV – without increasing sexual risk behavior.